VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ABCL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ABCLAbCellera Biologics Inc.
$7.69$2.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksABCLQuarterly Financials

AbCellera Biologics Inc. (ABCL) Quarterly Financials

120+ quarters historyFree accessUpdated daily

AbCellera Biologics Inc. (ABCL) quarterly income statement — complete revenue, gross profit & net income history

ABCL Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue8.31M44.85M8.96M17.08M4.24M5.05M6.51M7.32M9.95M9.18M6.6M10.06M12.19M21.55M101.38M45.92M316.58M139.33M5.51M27.64M
Revenue Growth %96.34%788.18%37.62%133.29%-57.45%-44.98%-1.39%-27.18%-18.36%-57.4%-93.49%-78.1%-96.15%-84.54%1740.65%66.11%56.15%-32.98%-41.17%146.2%
Cost of Goods Sold8.65M7.92M000000000001.55M15.04M5.21M44.64M21.89M03.61M
COGS % of Revenue104.09%17.66%-----------7.21%14.83%11.35%14.1%15.71%-13.06%
Gross Profit-340K36.93M8.96M17.08M4.24M5.05M6.51M7.32M9.95M9.18M6.6M10.06M12.19M19.99M86.35M40.71M271.94M117.44M5.51M24.03M
Gross Margin %-4.09%82.34%100%100%100%100%100%100%100%100%100%100%100%92.79%85.17%88.65%85.9%84.29%100%86.94%
Gross Profit Growth %-108.03%631.35%37.62%133.29%-57.45%-44.98%-1.39%-27.18%-18.36%-54.08%-92.36%-75.3%-95.52%-82.98%1467.68%69.38%48.82%--41.17%114.05%
Operating Expenses57.18M65.52M85.23M66.67M66.89M77.81M100.17M100.78M64.85M75.23M61.49M61.45M77.07M57.77M48.61M49.1M46.99M35.88M33.6M31.07M
OpEx % of Revenue687.66%146.07%951.79%390.24%1579.58%1540.69%1539.42%1376.17%651.48%819.61%931.79%611.03%632.1%268.13%47.95%106.94%14.84%25.75%610.09%112.38%
Selling, General & Admin10.52M15.42M24.96M21.99M19.07M19.16M22.28M23.33M20.72M19.07M17.84M19.36M18.91M15.71M16.88M17.53M16.64M14.72M12.49M12.5M
SG&A % of Revenue126.48%34.38%278.7%128.69%450.25%379.49%342.43%318.56%208.13%207.8%270.3%192.54%155.06%72.9%16.65%38.18%5.26%10.56%226.72%45.21%
Research & Development46.66M50.09M55.03M39.21M42.5M46.08M40.97M40.93M39.29M48.62M37.92M36.47M52.65M28.25M26.58M26.68M26.37M17.21M17.45M15.05M
R&D % of Revenue561.18%111.68%614.49%229.53%1003.45%912.4%629.61%558.88%394.69%529.71%574.59%362.7%431.82%131.1%26.22%58.12%8.33%12.35%316.81%54.43%
Other Operating Expenses001000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income-57.52M-28.58M-76.28M-49.59M-62.66M-72.75M-93.66M-93.45M-54.89M-66.05M-54.89M-51.39M-64.87M-37.78M37.73M-8.4M224.95M81.55M-28.1M-7.03M
Operating Margin %-691.75%-63.72%-851.79%-290.24%-1479.58%-1440.69%-1439.42%-1276.17%-551.48%-719.61%-831.79%-511.03%-532.1%-175.34%37.22%-18.29%71.06%58.53%-510.09%-25.44%
Operating Income Growth %8.2%60.71%18.56%46.94%-14.15%-10.15%-70.64%-81.86%15.38%-74.85%-245.46%-512.07%-128.84%-146.32%234.31%-19.38%42.31%-49.27%-1489.14%-723.54%
EBITDA-48.86M-20.66M-69.04M-42.52M-56.05M-58.85M-55.37M-55.42M-48.13M-56.94M-47.48M-44.13M-57.75M-22.42M44.46M-2.35M229.92M86.42M-23.89M-2.82M
EBITDA Margin %-587.66%-46.07%-770.99%-248.92%-1323.61%-1165.45%-850.9%-756.75%-483.5%-620.37%-719.52%-438.87%-473.7%-104.05%43.86%-5.13%72.63%62.02%-433.73%-10.19%
EBITDA Growth %12.83%64.89%-24.7%23.26%-16.47%-3.36%-16.61%-25.57%16.67%-154.01%-206.79%-1774.01%-125.12%-125.94%286.12%16.43%41.89%-47.11%-2774.85%-1346.9%
D&A (Non-Cash Add-back)8.65M7.92M7.24M7.06M6.61M13.9M38.3M38.04M6.77M9.11M7.41M7.26M7.12M15.36M6.73M6.04M4.97M4.86M4.21M4.21M
EBIT-57.52M-28.58M-73.55M-45.89M-58.51M-69.21M-90.17M-90.14M-51.62M-62.68M-52.06M-46.81M-61.5M-20.02M39.88M-6.86M230.14M89.34M-23.72M-2.39M
Net Interest Income3.64M5.92M6.76M7.59M8.05M8.67M9.6M9.8M10.4M10.97M10.74M10.78M9.76M05.56M1.41M665K000
Interest Income3.64M5.92M6.76M7.59M8.05M8.67M9.6M9.8M10.4M10.97M10.74M10.78M9.76M05.56M1.41M665K000
Interest Expense00000000000000000000
Other Income/Expense7.98M9.08M7.51M13.24M9.68M25.93M31.03M45.27M12.15M17.45M15.61M13.38M16.73M6.37M8.85M1.51M5.86M3.16M3.12M4.96M
Pretax Income-49.54M-19.5M-68.77M-36.34M-52.98M-46.83M-62.63M-48.19M-42.75M-48.6M-39.28M-38M-48.15M-31.41M46.59M-6.89M230.81M84.71M-24.97M-2.07M
Pretax Margin %-595.75%-43.47%-767.93%-212.74%-1251.1%-927.31%-962.53%-658.02%-429.45%-529.49%-595.18%-377.92%-394.91%-145.8%45.95%-15%72.91%60.8%-453.38%-7.5%
Income Tax-6.37M-10.55M-11.65M-1.62M-7.36M-12.62M-11.53M-11.26M-2.14M-1.45M-10.67M-7.48M-8.04M-1.52M19.96M-101K62.24M24.76M-3.59M250K
Effective Tax Rate %12.86%54.13%16.94%4.45%13.9%26.95%18.4%23.36%5%2.99%27.16%19.67%16.69%4.84%42.85%1.47%26.96%29.23%14.38%-12.06%
Net Income-43.16M-8.95M-57.12M-34.73M-45.62M-34.21M-51.11M-36.93M-40.61M-47.15M-28.61M-30.53M-40.11M-29.89M26.62M-6.79M168.57M59.95M-21.38M-2.32M
Net Margin %-519.12%-19.94%-637.84%-203.27%-1077.24%-677.43%-785.42%-504.3%-407.98%-513.67%-433.55%-303.58%-328.99%-138.75%26.26%-14.78%53.25%43.03%-388.16%-8.4%
Net Income Growth %5.38%73.85%-11.76%5.97%-12.34%27.44%-78.63%-20.97%-1.25%-57.73%-207.46%-349.93%-123.79%-149.86%224.53%-192.08%43.81%-48.76%-693.91%-134.66%
Net Income (Continuing)-43.16M-8.95M-57.12M-34.73M-45.62M-34.21M-51.11M-36.93M-40.61M-47.15M-28.61M-30.53M-40.11M-29.89M26.62M-6.79M168.57M59.95M-21.38M-2.32M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.14-0.03-0.19-0.12-0.15-0.12-0.17-0.13-0.14-0.16-0.10-0.11-0.14-0.100.08-0.020.540.19-0.08-0.01
EPS Growth %6.67%75%-11.76%7.69%-7.14%25%-70%-18.18%0%-61.29%-225%-450%-125.93%-152.21%200%-100%45.95%-48.65%-692.08%-135.46%
EPS (Basic)-0.14-0.03-0.19-0.12-0.15-0.12-0.17-0.13-0.14-0.16-0.10-0.11-0.14-0.100.09-0.020.590.21-0.08-0.01
Diluted Shares Outstanding303.07M298.71M298.88M298.51M297.69M294.59M294.85M294.22M292.72M290.95M289.5M288.91M287.77M301.3M315.82M284.69M311.48M314.89M278.93M272.2M
Basic Shares Outstanding303.07M298.71M298.88M298.51M297.69M294.59M294.85M294.22M292.72M290.95M289.5M288.91M287.77M286.41M285.32M284.69M283.9M279.83M278.93M272.2M
Dividend Payout Ratio--------------------